Abstract:Background: The traumatic spinal cord injury (SCI) can cause immediate multi-faceted function loss or paralysis. Microglia, as one of tissue resident macrophages, has been reported to play a critical role in regulating inflammation response during SCI processes. And transplantation with M2 microglia into SCI mice promotes recovery of motor function. However, the M2 microglia can be easily re-educated and changed their phenotype due to the stimuli of tissue microenvironment. This study aimed to find a way to maintain the function of M2 microglia, which could exert an anti-inflammatory and pro-repair role, and further promote the repair of spinal cord injury. Methods: To establish a standard murine spinal cord clip compression model using Dumont tying forceps. Using FACS, to sort microglia from C57BL/6 mice or CX3CR1GFP mice, and further culture them in vitro with different macrophage polarized medium. Also, to isolate primary microglia using density gradient centrifugation with the neonatal mice. To transfect miR-145a-5p into M2 microglia by Lipofectamine2000, and inject miR-145a-5p modified M2 microglia into the lesion sites of spinal cord for cell transplanted therapy. To evaluate the recovery of motor function in SCI mice through behavior analysis, immunofluorescence or histochemistry staining, Western blot and qRT-PCR detection. Application of reporter assay and molecular biology experiments to reveal the mechanism of miR-145a-5p modified M2 microglia therapy on SCI mice. Results: With in vitro experiments, we found that miR-145a-5p was highly expressed in M2 microglia, and miR-145a-5p overexpression could suppress M1 while promote M2 microglia polarization. And then delivery of miR-145a-5p overexpressed M2 microglia into the injured spinal cord area significantly accelerated locomotive recovery as well as prevented glia scar formation and neuron damage in mice, which was even better than M2 microglia transplantation. Further mechanisms showed that overexpressed miR-145a-5p in microglia inhibited the inflammatory response and maintained M2 macrophage phenotype by targeting TLR4/NF-κB signaling. Conclusions: These findings indicate that transplantation of miR-145a-5p modified M2 microglia has more therapeutic potential for SCI than M2 microglia transplantation from epigenetic perspective.

Protocol for Microglia Replacement by Peripheral Blood (mr PB)

Microglia replacement by bone marrow transplantation (Mr BMT) in the central nervous system of adult mice

Microglia replacement by microglia transplantation (Mr MT) in the adult mouse brain.

Efficient Strategies for Microglia Replacement in the Central Nervous System (vol 32, 108041-14.E1, 2020)

Efficient Strategies for Microglia Replacement in the Central Nervous System

Protocol for Primary Microglial Culture Preparation.

Evaluate the efficiency of Mr BMT in macrophage replacement of peripheral organs

Treatment of a genetic brain disease by CNS-wide microglia replacement

Allogenic microglia replacement: A novel therapeutic strategy for neurological disorders

Microglia replacement effectively attenuates the disease progress of ALSP in the mouse model and human patient

Restorative therapy using microglial depletion and repopulation for central nervous system injuries and diseases

Protocol for brain-wide or region-specific microglia depletion and repopulation in adult mice

Human iPSC-derived Microglial Cells Integrated into Mouse Retina and Recapitulated Features of Endogenous Microglia

Engineering of Human Blood-Induced Microglia-like Cells for Reverse-Translational Brain Research

Human-induced pluripotent stem cell-derived microglia integrate into mouse retina and recapitulate features of endogenous microglia

Taming microglia: the promise of engineered microglia in treating neurological diseases

Transplantation of miR-145a-5p modified M2 type microglia promotes the tissue repair of spinal cord injury in mice

Microglial repopulation induced by PLX3397 protects against ischemic brain injury by suppressing neuroinflammation in aged mice

Microglia-specific transduction via AAV11 armed with IBA1 promoter and miRNA-9 targeting sequences

Engineering an inhibitor-resistant human CSF1R variant for microglia replacement

A versatile mouse model to advance human microglia transplantation research in neurodegenerative diseases